(APPN) Appian - Overview
Stock: Platform, Automation, Intelligence, Mining, Services
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 48.3% |
| Relative Tail Risk | -7.02% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.34 |
| Alpha | -42.15 |
| Character TTM | |
|---|---|
| Beta | 0.991 |
| Beta Downside | 0.843 |
| Drawdowns 3y | |
|---|---|
| Max DD | 52.18% |
| CAGR/Max DD | -0.31 |
Description: APPN Appian January 14, 2026
Appian Corp. (NASDAQ:APPN) develops the Appian Platform, a low-code automation suite that combines AI, process automation, data fabric, and process-mining capabilities to let enterprises model, execute, and continuously improve critical workflows. The company sells the platform and related professional services to a broad set of verticals-including financial services, government, life sciences, insurance, manufacturing, energy, healthcare, telecom, and transportation-across North America, Europe, Asia-Pacific and other regions.
In FY 2023 the firm reported revenue of roughly $751 million, a year-over-year increase of about 15%, and total contract-value annual recurring revenue (ARR) surpassed $1.2 billion. Net dollar retention (NDR) has consistently exceeded 120%, indicating strong upsell and cross-sell dynamics, while gross margin remains near 80% due to the software-as-a-service model.
The low-code market is a key macro driver: research from IDC projects a compound annual growth rate of ~20% through 2029 as enterprises accelerate digital transformation and seek to reduce development backlogs. Appian’s focus on “process-centric” automation positions it to capture a share of this expanding spend, especially as public-sector budgets for workflow modernization remain resilient.
Investors should watch the pacing of enterprise IT budgets-particularly in the United States and Europe-as a slowdown could pressure new-logo growth, while the company’s high NDR and expanding ARR base provide a buffer against short-term headwinds.
For a deeper dive into APPN’s valuation metrics, you might explore the analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: -7.31m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 15.49 > 1.0 |
| NWC/Revenue: 10.03% < 20% (prev 10.41%; Δ -0.38% < -1%) |
| CFO/TA 0.12 > 3% & CFO 75.6m > Net Income -7.31m |
| Net Debt (181.4m) to EBITDA (28.3m): 6.41 < 3 |
| Current Ratio: 1.19 > 1.5 & < 3 |
| Outstanding Shares: last quarter (74.6m) vs 12m ago 3.01% < -2% |
| Gross Margin: 76.28% > 18% (prev 0.75%; Δ 7553 % > 0.5%) |
| Asset Turnover: 118.9% > 50% (prev 108.3%; Δ 10.61% > 0%) |
| Interest Coverage Ratio: 0.85 > 6 (EBITDA TTM 28.3m / Interest Expense TTM 21.6m) |
Altman Z'' -3.29
| A: 0.11 (Total Current Assets 439.4m - Total Current Liabilities 370.1m) / Total Assets 611.7m |
| B: -0.99 (Retained Earnings -605.8m / Total Assets 611.7m) |
| C: 0.03 (EBIT TTM 18.4m / Avg Total Assets 580.8m) |
| D: -0.97 (Book Value of Equity -641.0m / Total Liabilities 660.3m) |
| Altman-Z'' Score: -3.29 = D |
Beneish M -3.11
| DSRI: 1.06 (Receivables 172.6m/140.2m, Revenue 690.8m/595.7m) |
| GMI: 0.98 (GM 76.28% / 75.02%) |
| AQI: 0.84 (AQ_t 0.18 / AQ_t-1 0.21) |
| SGI: 1.16 (Revenue 690.8m / 595.7m) |
| TATA: -0.14 (NI -7.31m - CFO 75.6m) / TA 611.7m) |
| Beneish M-Score: -3.11 (Cap -4..+1) = AA |
What is the price of APPN shares?
Over the past week, the price has changed by -13.52%, over one month by -23.43%, over three months by -14.69% and over the past year by -25.48%.
Is APPN a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 6
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the APPN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 41 | 58.6% |
| Analysts Target Price | 41 | 58.6% |
| ValueRay Target Price | 22.8 | -12% |
APPN Fundamental Data Overview February 03, 2026
P/S = 2.9902
P/B = 53.977
Revenue TTM = 690.8m USD
EBIT TTM = 18.4m USD
EBITDA TTM = 28.3m USD
Long Term Debt = 233.6m USD (from longTermDebt, last quarter)
Short Term Debt = 25.2m USD (from shortTermDebt, last quarter)
Debt = 306.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 181.4m USD (from netDebt column, last quarter)
Enterprise Value = 2.18b USD (2.07b + Debt 306.6m - CCE 191.6m)
Interest Coverage Ratio = 0.85 (Ebit TTM 18.4m / Interest Expense TTM 21.6m)
EV/FCF = 30.02x (Enterprise Value 2.18b / FCF TTM 72.6m)
FCF Yield = 3.33% (FCF TTM 72.6m / Enterprise Value 2.18b)
FCF Margin = 10.52% (FCF TTM 72.6m / Revenue TTM 690.8m)
Net Margin = -1.06% (Net Income TTM -7.31m / Revenue TTM 690.8m)
Gross Margin = 76.28% ((Revenue TTM 690.8m - Cost of Revenue TTM 163.8m) / Revenue TTM)
Gross Margin QoQ = 75.78% (prev 74.26%)
Tobins Q-Ratio = 3.56 (Enterprise Value 2.18b / Total Assets 611.7m)
Interest Expense / Debt = 1.73% (Interest Expense 5.31m / Debt 306.6m)
Taxrate = 14.95% (1.38m / 9.20m)
NOPAT = 15.6m (EBIT 18.4m * (1 - 14.95%))
Current Ratio = 1.19 (Total Current Assets 439.4m / Total Current Liabilities 370.1m)
Debt / Equity = -6.32 (negative equity) (Debt 306.6m / totalStockholderEquity, last quarter -48.5m)
Debt / EBITDA = 6.41 (Net Debt 181.4m / EBITDA 28.3m)
Debt / FCF = 2.50 (Net Debt 181.4m / FCF TTM 72.6m)
Total Stockholder Equity = -41.7m (last 4 quarters mean from totalStockholderEquity)
RoA = -1.26% (Net Income -7.31m / Total Assets 611.7m)
RoE = 17.55% (negative equity) (Net Income TTM -7.31m / Total Stockholder Equity -41.7m)
RoCE = 9.56% (EBIT 18.4m / Capital Employed (Equity -41.7m + L.T.Debt 233.6m))
RoIC = 7.58% (NOPAT 15.6m / Invested Capital 205.8m)
WACC = 8.52% (E(2.07b)/V(2.37b) * Re(9.57%) + D(306.6m)/V(2.37b) * Rd(1.73%) * (1-Tc(0.15)))
Discount Rate = 9.57% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.86%
[DCF Debug] Terminal Value 69.91% ; FCFF base≈72.6m ; Y1≈52.1m ; Y5≈28.3m
Fair Price DCF = 7.28 (EV 492.7m - Net Debt 181.4m = Equity 311.3m / Shares 42.7m; r=8.52% [WACC]; 5y FCF grow -33.32% → 2.90% )
[DCF Warning] FCF declining rapidly (-33.32%), DCF may be unreliable
EPS Correlation: 68.84 | EPS CAGR: 3.61% | SUE: -0.46 | # QB: 0
Revenue Correlation: 98.40 | Revenue CAGR: 16.64% | SUE: 4.0 | # QB: 6
EPS next Quarter (2026-03-31): EPS=0.15 | Chg30d=+0.000 | Revisions Net=+2 | Analysts=7
EPS next Year (2026-12-31): EPS=0.77 | Chg30d=+0.000 | Revisions Net=+6 | Growth EPS=+42.0% | Growth Revenue=+11.6%